These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 33266043)

  • 1.
    Huang XF; Sheu GT; Chang KF; Huang YC; Hung PH; Tsai NM
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33266043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo.
    Huang NC; Huang RL; Huang XF; Chang KF; Lee CJ; Hsiao CY; Lee SC; Tsai NM
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extract Derived from
    Huang XF; Chang KF; Lee SC; Sheu GT; Li CY; Weng JC; Hsiao CY; Tsai NM
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33050385
    [No Abstract]   [Full Text] [Related]  

  • 4. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
    Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
    Yao S; Ye J; Yin M; Yu R
    Cancer Lett; 2020 Jul; 483():87-97. PubMed ID: 32268165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.
    Baek SY; Hwang UW; Suk HY; Kim YW
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32375410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma.
    Zhang B; Wang X; Deng J; Zheng H; Liu W; Chen S; Tian J; Wang F
    Cancer Lett; 2019 Sep; 459():50-58. PubMed ID: 31163195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
    Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
    Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
    Yang C; Qin S
    Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Wang Y; Dong L; Li J; Luo M; Shang B
    Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
    BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).
    Li Y; Wang W; Xu X; Sun S; Qu XJ
    Biomed Pharmacother; 2015 Feb; 69():125-32. PubMed ID: 25661348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway.
    Yan H; Jung KH; Kim J; Rumman M; Oh MS; Hong SS
    Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quinazoline derivative, 04NB-03, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells in a reactive oxygen species-dependent manner.
    Wang R; Zhu Y; Chen J; Wang Y; Song X; Wu Y; Jin F; Wang Y
    Chem Biol Interact; 2021 Apr; 338():109371. PubMed ID: 33582112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.
    Chen X; Zhu N; Wu Y; Zhang Y; Zhang Y; Jin K; Zhou Z; Chen G; Wang J
    Phytomedicine; 2024 Jun; 128():155317. PubMed ID: 38537439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mito-LND and (E)-Akt inhibitor-IV: novel compounds inducing endoplasmic reticulum stress and ROS accumulation against hepatocellular carcinoma.
    Liao S; Wang Q; Chen S; Huang Q; Zhou L; Liu H; He S; Zhou Z
    J Transl Med; 2024 Aug; 22(1):792. PubMed ID: 39198815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
    Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
    Oncotarget; 2014 May; 5(9):2853-63. PubMed ID: 24797310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.